Eli Lilly receives approval from the CDSCO Panel to investigate the antidiabetic medication Orforglipron.

Published Date: 30 Oct 2023

New Delhi: Under the Central Drug Standard Control, the Subject Expert Committee (SEC) has granted approval to the pharmaceutical giant Eli Lilly.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Researchers find distinct cell receptors with the potential for new treatments.

2.

Breast cancer patients' arms swell less after an effective lymph node transfer.

3.

Telehealth in the pandemic era resulted in fewer therapy interruptions.

4.

Too Many Chest CTs for Incidental Lung Nodules?

5.

Global warming could be driving up women's cancer risk, find researchers


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot